Article

Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expression

2024-10-27

Abstract excerpt

TNBC is the most aggressive breast cancer subtype, with a higher recurrence rate. TNBC proportion within breast cancer incidence in the Indian population is 22-30%. Despite the high incidence rate, the heterogeneity within TNBC subtype in Indian cohorts is not studied at scale. Here, leveraging an Indian cohort of 93 TNBC patients, we evaluated the basal and LAR subtypes in terms of the expression of known markers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87488599-e273-5172-8b59-75809cd03e39
DOI: 10.1101/2024.10.25.24316141

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expressionDOI 10.1101/2024.10.25.24316141Read

A comprehensive analysis of immune landscape of Indian triple negative breast cancerSemantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast CancerSemantic proximity Read

Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication.Semantic proximity Read

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancerSemantic proximity Read

Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity Read

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Targeting basal-like breast cancers.Semantic proximity Read

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to EthnicitySemantic proximity Read